Retour
Fourchette du Jour
3,27 €
3,35 €
Fourchette 52 Semaines
1,89 €
6,52 €
Volume
2 045 398
Moyenne 50J / 200J
3,62 €
/
4,10 €
Clôture Précédente
3,36 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (627 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | -6,9 | 0,3 |
| P/B | 0,9 | 2,9 |
| ROE % | -13,3 | 3,7 |
| Net Margin % | -194,9 | 3,8 |
| Rev Growth 5Y % | -33,1 | 10,0 |
| D/E | 0,1 | 0,2 |
Objectif de Cours des Analystes
Hold
20,17 €
+509.4%
Low: 5,00 €
High: 34,00 €
BPA Prévisionnel
-0,65 €
CA Est.
30 M
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2030 |
-0,59 €
-1,17 € – -0,34 €
|
120 M | 1 |
| FY2029 |
-0,75 €
-1,48 € – -0,42 €
|
72 M | 1 |
| FY2028 |
-0,78 €
-0,85 € – -0,65 €
|
55 M | 3 |
Points Clés
Revenue declined -33,11% annually over 5 years
Debt/Equity of 0,13 — conservative balance sheet
Negative free cash flow of -174,07M
PEG of 0,64 suggests growth is underpriced
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 193,67%
Capital intensive — 56,93% of revenue goes to capex
Croissance
Revenue Growth (5Y)
-33,11%
Revenue (1Y)160,56%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Qualité
Return on Equity
-13,33%
ROIC-12,68%
Net Margin-194,88%
Op. Margin-288,98%
Sécurité
Debt / Equity
0,13
Current Ratio11,32
Interest Coverage0,00
Valorisation
P/E Ratio
-6,85
P/B Ratio0,88
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 160,56% | Revenue Growth (3Y) | 40,56% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | -33,11% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 75,13M | Net Income (TTM) | -146,41M |
| ROE | -13,33% | ROA | -10,79% |
| Gross Margin | 100,00% | Operating Margin | -288,98% |
| Net Margin | -194,88% | Free Cash Flow (TTM) | -174,07M |
| ROIC | -12,68% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,13 | Current Ratio | 11,32 |
| Interest Coverage | 0,00 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -6,85 | P/B Ratio | 0,88 |
| P/S Ratio | 13,36 | PEG Ratio | 0,64 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 1,00B | Enterprise Value | 991,66M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 75,13M | 28,83M | 38,03M | 485,42M | 375,20M |
| Net Income | -146,41M | -162,86M | -146,40M | 158,52M | 153,46M |
| EPS (Diluted) | -0,49 | -0,55 | -0,51 | 0,50 | 0,48 |
| Gross Profit | 75,13M | 28,83M | 38,03M | 418,99M | 329,69M |
| Operating Income | -217,10M | -314,77M | -237,21M | 216,51M | 204,41M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 1,36B | 1,36B | 1,49B | 1,54B | 1,32B |
| Total Liabilities | 215,59M | 304,47M | 335,78M | 307,63M | 292,84M |
| Shareholders' Equity | 1,14B | 1,06B | 1,15B | 1,23B | 1,03B |
| Total Debt | 143,22M | 65,36M | 77,38M | 82,26M | 40,07M |
| Cash & Equivalents | 155,01M | 156,33M | 133,32M | 386,54M | 476,14M |
| Current Assets | 728,23M | 751,37M | 871,99M | 1,03B | 929,80M |
| Current Liabilities | 64,31M | 76,61M | 119,01M | 118,32M | 120,68M |